title: Apolipoprotein A-II influences the substrate properties of human HDL2 and HDL3 for hepatic lipase.
abstract: Hepatic lipase has a demonstrated dual role in plasma lipid transport in that it participates in the removal of remnants of triglyceride-rich lipoproteins from the circulation and in the metabolism of plasma HDL. The study presented here investigated the substrate properties for hepatic lipase of HDL differing in density and apolipoprotein (apo) composition. Rates of fatty acid liberation were twofold higher in HDL2 compared with the respective HDL3 subspecies. Within each density class, enzyme-catalyzed fatty acid release was nearly twofold higher from HDL containing apoA-II compared with HDL devoid of apoA-II. When native HDL3 devoid of apoA-II was reconstituted with dimeric apoA-II in vitro, rates of fatty acid liberation in reconstituted particles were similar to those in native HDL3 containing apoA-II. HDL containing apoA-II competed more effectively with small VLDL for binding of hepatic lipase than HDL devoid of apoA-II. HDL3, particularly apoA-II-containing HDL3, reduced lipolysis of triglyceride and total fatty acid liberation in small VLDL. We conclude that the substrate properties of HDLs for hepatic lipase are influenced by both their size and apoA-II content. Moreover, size as well as apoA-II content may indirectly affect remnant clearance.
authors.affiliation: Department of Medicine, Baylor College of Medicine, Houston, Tex, USA.
authors.forename: H O
authors.initials: HO
authors.lastname: Mowri
authors.forename: J R
authors.initials: JR
authors.lastname: Patsch
authors.forename: A M
authors.initials: AM
authors.lastname: Gotto
authors.forename: W
authors.initials: W
authors.lastname: Patsch
mesh_terms: D016633:Apolipoprotein A-II / Q000494:pharmacology*; D002914:Chylomicrons / Q000378:metabolism; D005227:Fatty Acids / Q000097:blood; D006801:Humans; D006868:Hydrolysis; D008049:Lipase / Q000378:metabolism*; D008075:Lipoproteins, HDL / Q000145:classification / Q000378:metabolism*; D008079:Lipoproteins, VLDL / Q000378:metabolism; D008099:Liver / Q000201:enzymology*; D013379:Substrate Specificity / Q000187:drug effects; D014280:Triglycerides / Q000097:blood
chemical_list: D016633:Apolipoprotein A-II; D002914:Chylomicrons; D005227:Fatty Acids; D008075:Lipoproteins, HDL; D008079:Lipoproteins, VLDL; D014280:Triglycerides; D008049:Lipase